Cizzle Biotechnology Holdings PLC (CIZ) - Cash Flow Conversion Efficiency

Latest as of June 2025: 1.199x

Based on the latest financial reports, Cizzle Biotechnology Holdings PLC (CIZ) has a cash flow conversion efficiency ratio of 1.199x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-331.00K ≈ $-40.27 USD) by net assets (GBX-276.00K ≈ $-33.58 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CIZ market cap overview for the company's overall valuation and market capitalisation.

Cizzle Biotechnology Holdings PLC - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Cizzle Biotechnology Holdings PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cizzle Biotechnology Holdings PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cizzle Biotechnology Holdings PLC ranked by their cash flow conversion efficiency. Explore CIZ cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Heavitree Brewery A LSE:HVTA	0.010x
Mind Gym Ltd LSE:MIND	0.214x
Crimson Tide plc LSE:TIDE	-0.014x
The Siam Cement Public Company Limited F:TCM1	0.018x
Novo Integrated Sciences Inc NASDAQ:NVOS	-0.037x
Eneraqua Technologies PLC LSE:ETP	0.014x
BENO Holding AG XETRA:BENH	N/A
Blackbird PLC LSE:BIRD	-0.118x

Annual Cash Flow Conversion Efficiency for Cizzle Biotechnology Holdings PLC (2006–2024)

The table below shows the annual cash flow conversion efficiency of Cizzle Biotechnology Holdings PLC from 2006 to 2024. View Cizzle Biotechnology Holdings PLC (CIZ) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	GBX82.00K ≈ $9.98	GBX-358.00K ≈ $-43.56	-4.366x	-929.63%
2023-12-31	GBX1.51 Million ≈ $183.36	GBX-639.00K ≈ $-77.75	-0.424x	-28.37%
2022-12-31	GBX2.64 Million ≈ $321.21	GBX-872.00K ≈ $-106.10	-0.330x	+69.33%
2021-12-31	GBX937.00K ≈ $114.01	GBX-1.01 Million ≈ $-122.77	-1.077x	+88.28%
2020-12-31	GBX32.00K ≈ $3.89	GBX-294.00K ≈ $-35.77	-9.188x	-761.46%
2019-12-31	GBX6.63K ≈ $0.81	GBX-7.07K ≈ $-0.86	-1.067x	-148.86%
2018-12-31	GBX-235.00K ≈ $-28.59	GBX-513.00K ≈ $-62.42	2.183x	+951.36%
2017-12-31	GBX741.00K ≈ $90.16	GBX-190.00K ≈ $-23.12	-0.256x	-401.49%
2016-12-31	GBX2.19 Million ≈ $266.09	GBX186.00K ≈ $22.63	0.085x	+135.88%
2015-12-31	GBX2.40 Million ≈ $292.62	GBX-570.00K ≈ $-69.35	-0.237x	-127.41%
2014-12-31	GBX5.05 Million ≈ $614.07	GBX-526.00K ≈ $-64.00	-0.104x	+34.38%
2013-12-31	GBX4.27 Million ≈ $519.41	GBX-678.00K ≈ $-82.49	-0.159x	-424.98%
2012-12-31	GBX4.79 Million ≈ $583.17	GBX-145.00K ≈ $-17.64	-0.030x	+91.82%
2011-12-31	GBX4.08 Million ≈ $496.90	GBX-1.51 Million ≈ $-183.72	-0.370x	-329.38%
2010-12-31	GBX3.54 Million ≈ $430.96	GBX-305.00K ≈ $-37.11	-0.086x	+70.09%
2009-12-31	GBX521.00K ≈ $63.39	GBX-150.00K ≈ $-18.25	-0.288x	+69.03%
2008-12-31	GBX1.67 Million ≈ $202.70	GBX-1.55 Million ≈ $-188.47	-0.930x	-6.47%
2007-12-31	GBX2.40 Million ≈ $291.89	GBX-2.10 Million ≈ $-254.90	-0.873x	-104.62%
2006-12-31	GBX-58.00K ≈ $-7.06	GBX-1.10 Million ≈ $-133.47	18.914x	--

About Cizzle Biotechnology Holdings PLC

LSE:CIZ UK Biotechnology

Market Cap

$77.17K

GBX634.23 Million GBX

Market Cap Rank

#31567 Global

#1157 in UK

Share Price

GBX1.60

Change (1 day)

+6.67%

52-Week Range

GBX1.29 - GBX3.65

All Time High

GBX1144.91